Whey-Leucine Omega-3 Composition for Cancer Cachexia Muscle Function

The patent combines whey protein, leucine, and ω-3 polyunsaturated fatty acids into a single nutritional composition. This merging of multiple beneficial components into one formulation allows the composition to effectively address muscle wasting and functional decline while maintaining ease of use and administration.

The nutritional composition functions as a composite material combining different nutritional components (whey protein, leucine, and ω-3 polyunsaturated fatty acids) that work synergistically. Each component contributes specific properties: whey protein provides essential amino acids, leucine stimulates protein synthesis, and ω-3 fatty acids reduce inflammation, together creating a formulation more effective than individual components alone.

The patent converts the harmful catabolic signal into a beneficial outcome by combining protein supplementation with ω-3 polyunsaturated fatty acids. The ω-3 fatty acids mitigate the catabolic signal and reduce inflammation, thereby converting the potentially harmful protein breakdown process into a net anabolic effect when combined with adequate protein intake.

The patent changes the nutritional parameters by not only increasing protein quantity but also adding specific components (leucine and ω-3 polyunsaturated fatty acids) that modify the metabolic response. This multi-parameter approach ensures both adequate substrate availability and optimization of the anabolic/catabolic balance.